@desertshores, can you share the brand you are using; checking Amazon, there seem to be quite a variation in costs and claims for efficacy.
I use the powder form, not that I think it is better. I whisk it in with a little blender.
Nutricost
C8 MCT Oil Powder 1LB (16.2oz) - 95% C8 MCT Oil Powder
I thought on posting this in a different topic just to warn everyone, the formulation is super important if you want ketones to be healthy:
âDivergent Hepatic Outcomes of Chronic Ketone Supplementation: Ketone Salts Preserve Liver Health While Ketone Esters and Precursors Drive Inflammation and Steatosisâ
https://www.mdpi.com/1424-8247/18/10/1436
This gives us light why the study shared in a post before this one showed increased mortality following ketone supplementation:
First of all, Salts seem to be the only formulation that is safe. Second, the speed at which you saturate the body seems to also be important. I imagine is the same as Fructose and alcohol, if the step needs ATP, the slower you ingest it, the less crisis you generate.
Conflicts of Interest
International Patent # PCT/US2014/031237, University of South Florida, D.P. DâAgostino, S. Kesl, Patrick Arnold, âCompositions and Methods for Producing Elevated and Sustained Ketosisâ. Patent: US 10,980,764 B1, C. Ari, D.P. DâAgostino, âExogenous ketone supplements for reducing anxiety-related behaviorâ; Ari, C., DâAgostino, D.P. Technology Title: âExogenous Ketone Supplementation Improved Motor Function in Sprague-Dawley Ratsâ. USF Ref. No: 16A019; Ari, C., DâAgostino, D.P. Technology Title: âLowering of Blood Glucose in Exercising and Non-Exercising Rats Following Administration of Exogenous Ketones and Ketone Formulasâ. USF Ref. No: 16A049; Ari, C., DâAgostino, D.P. Technology Title: âNeuroregeneration improved by ketoneâ. USF Ref. No: 16B128 (provisional patent); Patent: US 10,945,975 B2: Ari, C., DâAgostino, D.P., Dean, J.B. Technology Title: âDelaying latency to seizure by combinations of ketone supplementsâ. Non provisional patent No. 210112â9018-US02 for AC and DPD. Technology Title: âMethods of Increasing Latency of Anesthetic Induction Using Ketone Supplementationâ. US Patent Application No. 17/576,375, patent: Z. Kovacs, C. Ari, D.P. DâAgostino: âKetone supplements evoked effect on absence epilepsy by coadministration of Uridineâ. D.P. DâAgostino and C. Ari are the co-owners of the company Ketone Technologies LLC, and C. Ari is the owner of Fortis World LLC. These interests have been reviewed and managed by the University in accordance with its Institutional and Individual Conflict of Interest policies. All authors declare that there are no additional conflicts of interest.
Adding to this that his wife founded ketone salt companies:
Another source supports that MCT causes steatosis in the liver. This time from a different lab and a different animal, mice:
https://www.sciencedirect.com/science/article/abs/pii/S0952327818301947
[quote=âViracocha, post:26, topic:4973â]
steatosis
Medium-chain triglyceride reinforce the hepatic damage caused by fructose intake in mice
Thatâs the title of the study, yes. If your point is that it only happened with fructose you should read the study. If your point is another one, please clarify.
I should have been more clear.
A. It is a mouse study: The correlation as it relates to humans is not that high, 20 - 40%
They used C57bl/6 mice, mice that are prone to have these results. This means that I have little respect for the study.
C57bl/6 mice:
Metabolism & body composition
- Prone to diet-induced obesity
- Rapid weight gain on high-fat diets
Develop:
- Insulin resistance
- Hyperglycemia
- Fatty liver (NAFLD)
Implication:
They over-respond to Western diets â metabolic interventions often look stronger than they are in humans.
- MCT (C-MCT) = detrimental hepatic effects and should be used with caution,
- Fructose (F) = increased water intake and blood pressure associated with hepatic steatosis.
- fructose with MCT (F-MCT) = showed hepatic steatosis and inflammation in the liver,
"Highlights
â˘Fructose increased liver lipogenesis and inflammation, and reduced beta-oxidation.
â˘MCT and fructose led to marked fat accumulation (steatosis) within the hepatocytes.
â˘MCT intake did not revert or attenuate the hepatic damage caused by fructose.
So, even with these mice, the effect of MCTs wasnât that great.
Ref1